We have located links that may give you full text access.
Calcitonin gene related peptide gene-modified rat bone mesenchymal stem cells are effective seed cells in tissue engineering to repair skull defects.
Histology and Histopathology 2019 March 22
The study is to verify whether Calcitonin gene related peptide (CGRP) gene-modified rat bone mesenchymal stem cells (BMSCs) are promising seed cells with great potential to repair bone defect. A recombinant lentiviral vector overexpressing CGRP peptide, pLenO-DCE-CGRP, was constructed and transfected into rBMSCs to obtain stable CGRP expression. Differently transfected rBMSCs: CGRP- modified rBMSCs (CGRP group), empty vector- modified rBMSCs (Vector group) and normal rBMSCs (Control group) were transferred to collagen scaffold to repair rat skull defects (n=6). Skull specimens were obtained at 4 and 8 weeks after operation. Expressions of osteogenesis-related indexes OCN (osteocalcin) and BMP-2 (Bone morphogenetic protein-2) were detected by immunohistochemistry and western blotting. Histological observation, Masson trichrome staining and Micro-computed tomography (Micro-CT) were applied to evaluate defect repair. Tartrate-resistant acid phosphatase (TRAP) was applied to observe bone remodeling at 4 weeks. PGP9.5 was detected to observe nerve fibers formation at 8 weeks. Osteogenic markers OCN and BMP-2 were significantly higher in CGRP -modified BMSCs at 4 weeks, compared with the vector and control groups. Few TRAP-positive expressions and scaffolds were observed in the CGRP group. More new bone formation and mineralization in defects were observed in the CGRP group at 4 and 8weeks. Many PGP9.5-positive expressions were found in the CGRP group. CGRP promoted osteogenic differentiation of BMSC and scaffold resorption in vivo. Repair effect of CGRP group was significantly better than the other two groups. CGRP gene-modified BMSCs are effective seed cells in tissue engineering to repair bone defects.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app